Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, with Oramed Pharmaceuticals, announced the development of an oral Covid-19 vaccine that …
Category:
New Launch
-
-
The account comes with many benefits including interest of up to seven per cent on balance. jjivan Small Finance Bank, Ua part …
-
TYRX is a value-based offering aimed at lowering infection risk and reducing readmission rates with the long-term goal of creating better outcomes. …
-
Premas, Oramed and other shareholders, have formed Oravax Medical, which has received exclusive licenses from Oramed and Premas to develop oral COVID-19 …
-
Hunar Haat is an effective platform for talented artisans and craftsmen from Indian villages. The Union Minister for Road Transport and Highways …